Loading candles…
Jubilant Ingrevia is a core entity within the Jubilant Bhartia Group, operating as a global provider of integrated life science products and innovative solutions. The company serves multiple industries including pharmaceutical, nutrition, agrochemical, consumer industrial, and specialty chemicals. Its product offerings encompass life science products, ingredients for pharmaceutical, agrochemical, nutrition, and consumer industrial sectors, as well as custom research and manufacturing services provided exclusively to pharmaceutical and agrochemical customers. Jubilant Ingrevia's business model emphasizes deep vertical integration concentrated on Pyridine and Diketene chemistry value chains. The company maintains a leadership position in the global specialty chemicals and nutrition markets, operating on a worldwide scale.
This page is a live market overview for JUBILANT INGREVIA LIMITED (JUBLINGREA) on the NSE. As a listed security, JUBILANT INGREVIA LIMITED is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for JUBLINGREA before placing trades on tick2trade.
As of the latest feed, JUBLINGREA last traded at ₹740.25 on NSE, down ₹16.75 (2.21%) from the previous close of ₹757. Today's session range is ₹733.65 – ₹766.6, against a 52-week band of ₹537.3 – ₹795. Traded volume today stands at 5.50L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for JUBLINGREA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether JUBLINGREA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for JUBILANT INGREVIA LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in JUBLINGREA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated JUBLINGREA option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 22 Jul 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 26 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 4 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and dividend | 4 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 31 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 13 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.